ScoreWhy is Scandinavian ChemoTech AB ?
1
With a growth in Net Sales of 55.38%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at SEK -9.48 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 2.86%
- OPERATING PROFIT(Q) Highest at SEK -0.1 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 135.67%, its profits have risen by 37.1%
3
Market Beating Performance
- The stock has generated a return of 135.67% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 8.01%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Scandinavian ChemoTech AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Scandinavian ChemoTech AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Scandinavian ChemoTech AB
135.67%
0.83
101.94%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
65.67%
EBIT Growth (5y)
7.58%
EBIT to Interest (avg)
-13.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
1.28
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
50.88
EV to EBIT
-11.97
EV to EBITDA
-15.35
EV to Capital Employed
66.27
EV to Sales
11.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-553.46%
ROE (Latest)
-486.78%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend31What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -9.48 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 2.86%
OPERATING PROFIT(Q)
Highest at SEK -0.1 MM
OPERATING PROFIT MARGIN(Q)
Highest at -2.58 %
RAW MATERIAL COST(Y)
Fallen by -92.69% (YoY
NET SALES(Q)
Highest at SEK 3.84 MM
PRE-TAX PROFIT(Q)
Highest at SEK -0.94 MM
NET PROFIT(Q)
Highest at SEK -0.94 MM
EPS(Q)
Highest at SEK -0.04
-7What is not working for the Company
INTEREST(9M)
At SEK 0.11 MM has Grown at inf%
ROCE(HY)
Lowest at -382.62%
CASH AND EQV(HY)
Lowest at SEK 1.53 MM
Here's what is working for Scandinavian ChemoTech AB
Net Sales
At SEK 3.84 MM has Grown at 99.71%
over average net sales of the previous four periods of SEK 1.92 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (SEK MM)
Operating Cash Flow
Highest at SEK -9.48 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Operating Profit
Highest at SEK -0.1 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (SEK MM)
Operating Profit Margin
Highest at -2.58 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debtors Turnover Ratio
Highest at 2.86% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Highest at SEK 3.84 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Pre-Tax Profit
Highest at SEK -0.94 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Pre-Tax Profit
At SEK -0.94 MM has Grown at 72.74%
over average net sales of the previous four periods of SEK -3.46 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK -0.94 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Net Profit
At SEK -0.94 MM has Grown at 72.74%
over average net sales of the previous four periods of SEK -3.46 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK -0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Raw Material Cost
Fallen by -92.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Scandinavian ChemoTech AB
Interest
At SEK 0.11 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Cash and Eqv
Lowest at SEK 1.53 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
